Supplementation of the Gail model with the BRCAPRO model allows for a much more efficient ascertainment of women at high risk for breast cancer specifically due to the possibility that they carry a mutant BRCA1 or BRCA2 gene, based on our accumulated knowledge of hereditary breast-ovarian cancer syndrome. The gene discussed is BRCA1; the disease is breast cancer.